[Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria].

[Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria]. Z Gastroenterol. 2020 Aug;58(8):785 Authors: Stölzel U PMID: 32785915 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32785915?dopt=Abstract

Source: Zeitschrift fur Gastroenterologie - July 31, 2020 Category: Gastroenterology Authors: Stölzel U Tags: Z Gastroenterol Source Type: research

More News: Gastroenterology | Porphyria